Alligator Bioscience AB (publ) — Form D

Alligator Bioscience AB (publ) of SE-223 81 LUND, V7, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-01. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (7)

NameRoleLocation
Peter BensonDirectorSE-223 81 LUND, V7
Carl BorrebaeckDirectorSE-223 81 LUND, V7
Claes EricssonDirectorSE-223 81 LUND, V7
JACOB LINDBERGDirectorROYAL OAK, MI
Kenth PeterssonDirectorSE-223 81 LUND, V7
Jonas SjogrenDirectorSE-223 81 LUND, V7
Mathias UhlenDirectorSE-223 81 LUND, V7

More